{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:12:02Z","timestamp":1792098722793,"version":"4.4.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00134-022-06913-9","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T18:03:52Z","timestamp":1666375432000},"page":"1818-1819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19"],"prefix":"10.1007","volume":"48","author":[{"given":"Nicol\u00e1s","family":"Colaianni-Alfonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Cesar","family":"Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Castro-Sayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-6308","authenticated-orcid":false,"given":"Domenico Luca","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"6913_CR1","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","volume":"199","author":"O Roca","year":"2019","unstructured":"Roca O, Caralt B, Messika J et al (2019) An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 199:1368\u20131376. https:\/\/doi.org\/10.1164\/rccm.201803-0589OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6913_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2022.0028","volume":"327","author":"GD Perkins","year":"2022","unstructured":"Perkins GD, Ji C, Connolly BA et al (2022) Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. JAMA 327:546\u2013558. https:\/\/doi.org\/10.1001\/jama.2022.0028","journal-title":"JAMA"},{"key":"6913_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.08.2221","author":"N Colaianni-Alfonso","year":"2022","unstructured":"Colaianni-Alfonso N, Montiel GC, Vega ML et al (2022) Helmet versus facemask CPAP in COVID-19 respiratory failure: a prospective cohort study. Chest. https:\/\/doi.org\/10.1016\/j.chest.2022.08.2221","journal-title":"Chest"},{"key":"6913_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1007\/s00134-020-06177-1","volume":"46","author":"N Zucman","year":"2020","unstructured":"Zucman N, Mullaert J, Roux D et al (2020) Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med 46:1924\u20131926. https:\/\/doi.org\/10.1007\/s00134-020-06177-1","journal-title":"Intensive Care Med"},{"key":"6913_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4187\/respcare.08622","volume":"66","author":"LS Menga","year":"2021","unstructured":"Menga LS, Cese LD, Bongiovanni F et al (2021) High failure rate of noninvasive oxygenation strategies in critically ill subjects with acute hypoxemic respiratory failure due to COVID-19. Respir Care 66:705\u2013714. https:\/\/doi.org\/10.4187\/respcare.08622","journal-title":"Respir Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-022-06913-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:23:14Z","timestamp":1669706594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-022-06913-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6913"],"URL":"https:\/\/doi.org\/10.1007\/s00134-022-06913-9","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"10 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DLG has received payments for travel expenses by Getinge and Air Liquide, speaking fees by Intersurgical, Gilead, Pfizer, General Electric Healthcare and Fisher & Paykel, and discloses a research grant by General Electric Healthcare. OR reported a research grant from Hamilton Medical AG, speaker fees from Hamilton Medical AG, Fisher & Paykel Healthcare Ltd, Aerogen Ltd and Ambu, and non-financial research support from Timpel; all outside the submitted work. The other authors have disclosed no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}